New analysis narrows the perceived edge of tirzepatide over semaglutide in weight loss for type 2 diabetes

A recent study challenges previous assumptions by showing that, when comparing doses directly, semaglutide’s effectiveness in weight reduction approaches that of tirzepatide, prompting a nuanced re-evaluation of their relative benefits. Average results have recently made tirzepatide look like the more…















